EUVIMEDEUVIMED entdecken
Crossref

Amphiphilic modification of human lysozyme enhances its ability to inhibit Aβ42 aggregation

Tomonori Waku, Rina Tokazu, Takaki Hori, Michiaki Okuda, Hachiro Sugimoto, Kazuya Matsuo, Akio Kobori

Chemistry Letters · 01.08.2026 · 55 (8)

DOI: 10.1093/chemle/upag146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry Letters, online erschienen am 06.08.2026. Verfasst von Tomonori Waku und 6 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human lysozyme (hLYZ) was sequentially PEGylated, conjugated with ethylenediamine, and propionylated to yield PEGylated, cationic, and amphiphilic derivatives, respectively. The ability of these derivatives to inhibit amyloid β 42 (Aβ42) aggregation was evaluated and compared with that of unmodified hLYZ. Among the hLYZ derivatives examined, amphiphilic hLYZ showed the strongest inhibition of Aβ42 aggregation. These results suggest that amphiphilic modification of hLYZ through the introduction of polyethylene glycol (PEG) and hydrophobic groups may be a useful strategy for improving its ability to inhibit Aβ42 aggregation.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Waku, T., Tokazu, R., Hori, T., Okuda, M., Sugimoto, H., Matsuo, K., & Kobori, A. (2026). Amphiphilic modification of human lysozyme enhances its ability to inhibit Aβ42 aggregation. Chemistry Letters, 55(8). https://doi.org/10.1093/chemle/upag146

Vancouver

Waku T, Tokazu R, Hori T, Okuda M, Sugimoto H, Matsuo K, et al. Amphiphilic modification of human lysozyme enhances its ability to inhibit Aβ42 aggregation. Chemistry Letters. 2026;55(8). doi:10.1093/chemle/upag146

BibTeX
@article{Waku2026,
  author = {Waku, Tomonori and Tokazu, Rina and Hori, Takaki and Okuda, Michiaki and Sugimoto, Hachiro and Matsuo, Kazuya and Kobori, Akio},
  title = {Amphiphilic modification of human lysozyme enhances its ability to inhibit Aβ42 aggregation},
  journal = {Chemistry Letters},
  year = {2026},
  volume = {55},
  number = {8},
  doi = {10.1093/chemle/upag146}
}
Kostenlos starten →